Tumor-targeting novel manganese complex induces ROS-mediated apoptotic and autophagic cancer cell death
Jia Liu1, Wenjie Guo1, Jing Li1
1School of Pharmacy, Jiangsu University, Zhenjiang, Jiangsu 212013, P.R. China.
Abstract:
In this study, the antitumor activity of the novel manganese (II) compound, Adpa-Mn {[(Adpa)Mn(Cl)(H(2)O)] (Adpa=bis(2-pyridylmethyl)amino-2-propionic acid)}, and its possible mechanisms of action were investigated. In vitro, the growth inhibitory effects of Adpa-Mn (with IC(50) values lower than 15 µM) on tumor cell lines were examined by MTT assay. We found that this compound was more selective against cancer cells than the popular chemotherapeutic reagent, cisplatin. We then found that Adpa-Mn achieved its selectivity against cancer cells through the transferrin (Tf)-transferrin receptor (TfR) system, which is highly expressed in tumor cells. Furthermore, Adpa-Mn induced both apoptosis and autophagy, as indicated by chromatin condensation, the activation of poly(ADP-ribose) polymerase (PARP), Annexin V/propidium iodide staining, an enhanced fluorescence intensity of monodansylcadaverine (MDC), as well as the elevated expression of the autophagy-related protein, microtubule-associated protein 1 light chain 3 (LC3). In addition, Adpa-Mn induced the generation of intracellular reactive oxygen species (ROS) and its anticancer effects were significantly reduced following pre-treatment with the antioxidant, N-acetyl cysteine, indicating that ROS triggered cell death. In vivo, the induction of apoptosis and autophagy in tumor tissue was confirmed following treatment with Adpa-Mn, which contributed to its significant antitumor activity against hepatocellular carcinoma (Hep-A cell) xenografts at 10 mg/kg. Taken together, these data suggest the possible use of Adpa-Mn as a novel anticancer drug.
Insights
A novel manganese compound, Adpa-Mn, shows potent antitumor activity by selectively targeting cancer cells via the transferrin receptor system. It induces apoptosis and autophagy, mediated by reactive oxygen species, offering potential as a new anticancer drug.
Area of Science:
- Inorganic Chemistry
- Cancer Biology
- Pharmacology
Background:
- The development of novel anticancer agents with improved selectivity and efficacy remains a critical challenge in oncology.
- Manganese compounds are being explored for their therapeutic potential, but their mechanisms of action require thorough investigation.
Purpose of the Study:
- To investigate the antitumor activity and mechanisms of a novel manganese (II) compound, Adpa-Mn.
- To evaluate the selectivity of Adpa-Mn against cancer cells compared to cisplatin.
- To elucidate the pathways, including apoptosis, autophagy, and reactive oxygen species generation, involved in Adpa-Mn's anticancer effects.
Main Methods:
- In vitro studies using MTT assay to determine growth inhibitory effects (IC50 values) on tumor cell lines.
- Investigation of Adpa-Mn's interaction with the transferrin (Tf)-transferrin receptor (TfR) system.
- Analysis of apoptosis and autophagy markers, including chromatin condensation, PARP activation, Annexin V/propidium iodide staining, MDC fluorescence, and LC3 expression.
- Assessment of intracellular reactive oxygen species (ROS) generation and the effect of N-acetyl cysteine pre-treatment.
- In vivo studies using hepatocellular carcinoma (Hep-A cell) xenografts in mice to evaluate antitumor activity.
Main Results:
- Adpa-Mn exhibited significant in vitro growth inhibition of tumor cell lines with IC50 values lower than 15 µM.
- The compound demonstrated greater selectivity against cancer cells than cisplatin.
- Adpa-Mn selectively entered cancer cells via the Tf-TfR system.
- Induction of apoptosis and autophagy was confirmed through various cellular and molecular markers.
- Adpa-Mn triggered intracellular ROS generation, which was crucial for its cell-killing effects.
- Significant antitumor activity was observed in vivo against hepatocellular carcinoma xenografts at a dose of 10 mg/kg, with confirmed apoptosis and autophagy in tumor tissues.
Conclusions:
- Adpa-Mn possesses significant antitumor activity, characterized by selective cancer cell targeting and induction of apoptosis and autophagy.
- The transferrin receptor-mediated uptake and ROS generation are key mechanisms underlying Adpa-Mn's efficacy.
- These findings suggest Adpa-Mn holds promise as a novel therapeutic agent for cancer treatment.
More Related Videos
Related Concept Videos
Electron Transport Chain: Complex I and II
ROS generation is regulated and maintained at moderate levels necessary...
Targeted Cancer Therapies
There are several types of targeted therapies against...
Autophagic Cell Death
Autophagy and Apoptosis
Autophagy can activate apoptosis. In normal conditions, the autophagy activating protein Beclin-1 and...
The Intrinsic Apoptotic Pathway
Cytotoxic T Cells-mediated Immune Response
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
The Extrinsic Apoptotic Pathway


